Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

Polymorphism In Endostatin, An Angiogenesis Inhibitor, And Prostate Cancer Risk And Survival: A Prospective Study
UroToday.com - Angiogenesis is the process of new blood vessel formation in tumors, facilitating their growth. Endostatin is a cleavage product of collagen and is a potent inhibitor of endothelial cell proliferation and migration. Endostatin causes apoptosis in endothelial and tumor cells. Prostate cancer expresses angiogenic factors.
generic viagra online
UCF Team's Advanced Nerve Cell System Could Help Cure Diabetic Neuropathy, Related Diseases
Multiple sclerosis, diabetic neuropathy, and other conditions caused by a loss of myelin insulation around nerves can be debilitating and even deadly, but adequate treatments do not yet exist. That"s in large part because of deficiencies in model research systems. In an upcoming issue of the journal Biomaterials, a UCF team addresses this problem with a report on the first lab-grown motor nerves that are insulated and organized the same way they are in the body. The group"s model system, along with further advances now within reach, could dramatically improve understanding of the causes of myelin-related conditions, and enable discovery and testing of new drug therapies.
News of the day
Extreme Sports Not About Risk-taking: Study
Those who think extreme sports are all about risk-taking are missing the point, according to a QUT researcher. Eric Brymer, a lecturer from the School of Human Movement Studies in the Faculty of Health, has been researching whether the element of risk was an important factor among participants in "extreme" sports such as waterfall kayakers, mountain climbers, big wave surfers and B.A.S.E. jumpers.
Oncology

Law Firm Appointed To Boost Fight Against NHS Fraud

A new partnership between NHS Counter Fraud and law firm Capsticks will strengthen support to health bodies seeking to recover NHS funds lost to fraud. The innovative new scheme enables NHS bodies to make use of an accessible and cost effective civil recovery service in an area previously considered high risk. Capsticks" services under the new agreement include: - an advice line provided by a team of lawyers highly experienced in helping NHS bodies to respond to fraud - full litigation service where required - flexible funding options, including competitive rates agreed with NHS Counter Fraud, fixed fees and, where appropriate, "no-win-no-fee" arrangements. Dermid McCausland, Managing Director of NHS Counter Fraud, said: "I very much look forward to working with Capsticks and am sure this initiative will act as a strong deterrent to any potential fraudsters. Our aim is of course to prevent fraud from happening in the first place but we can now send a very clear message to those who do commit fraud: fraud against the NHS doesn"t pay and, wherever possible, we will be seeking financial recovery." Daniel Purcell, the Partner leading the work at Capsticks, said: "We are delighted to be working with NHS Counter Fraud to energise fraud response across the NHS. We look forward to bringing our experience and expertise in working with NHS bodies in countering fraud to this vitally important and high profile work." NHS Counter Fraud Service


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009